pharma_company
stringclasses 562
values | brand_name_en
stringlengths 19
232
| generic_name_en
stringlengths 21
250
| substance_name_en
stringclasses 983
values | atc_code_raw
stringclasses 778
values | anatomical_desc
stringclasses 14
values | therapeutic_desc
stringclasses 82
values | pharmacological_desc
stringclasses 181
values | subpharmacological_desc
stringclasses 365
values | chemical_desc
stringclasses 636
values |
---|---|---|---|---|---|---|---|---|---|
Sana Med Pharmaceutical
|
VITAMIN B1-SANA MED TABLET ORAL 300 mg
|
VITAMIN B1 (THIAMINE) TABLET ORAL 300 mg
|
VITAMIN B1 (THIAMINE)
|
A11DA01
|
ALIMENTARY TRACT AND METABOLISM
|
VITAMINS
|
VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12
|
Vitamin B1, plain
|
thiamine (vit B1)
|
Sobhandarou
|
CITALOPRAM TABLET ORAL 20 mg
|
CITALOPRAM TABLET ORAL 20 mg
|
CITALOPRAM
|
N06AB04
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Selective serotonin reuptake inhibitors
|
citalopram
|
Toliddaru Pharma. Co.
|
METOPROLOL TARTRATE TABLET ORAL 50 mg
|
METOPROLOL TARTRATE TABLET ORAL 50 mg
|
METOPROLOL TARTRATE
|
C07AB02
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
metoprolol
|
Loghman Pharmaceutical & Hygienic (public)
|
ACETAMINOPHEN/CODEINE TABLET ORAL 300 mg/20 mg
|
ACETAMINOPHEN / CODEINE PHOSPHATE TABLET ORAL 300 mg/20 mg
|
ACETAMINOPHEN / CODEINE PHOSPHATE
|
N02BE71
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol, combinations with psycholeptics
|
Teb-mofid-nikan
|
GABAPENTIN CAPSULE ORAL 100 mg
|
GABAPENTIN CAPSULE ORAL 100 mg
|
GABAPENTIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
PSORIABET OINTMENT TOPICAL 0.005 %/0.064 % 30 g
|
CALCIPOTRIOL / BETAMETHASONE DIPROPIONATE OINTMENT TOPICAL 0.005 %/0.064 % 30 g
|
CALCIPOTRIOL / BETAMETHASONE DIPROPIONATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sepidaj Pharmaceutical Company
|
CLINDAMYCIN-SEPIDAJ SOLUTION TOPICAL 10 mg/1mL 60 mL
|
CLINDAMYCIN (AS PHOSPHATE) SOLUTION TOPICAL 10 mg/1mL 60 mL
|
CLINDAMYCIN (AS PHOSPHATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
KETOTIFEN-HAKIM SYRUP ORAL 1 mg/5mL 120 mL
|
KETOTIFEN SYRUP ORAL 1 mg/5mL 120 mL
|
KETOTIFEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
SERTRALINE TABLET ORAL 50 mg
|
SERTRALINE (AS HYDROCHLORIDE) TABLET ORAL 50 mg
|
SERTRALINE (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Behvazan Pharmaceutical
|
DALAZAN SOLUTION TOPICAL 10 mg/1mL 60 mL
|
CLINDAMYCIN (AS PHOSPHATE) SOLUTION TOPICAL 10 mg/1mL 60 mL
|
CLINDAMYCIN (AS PHOSPHATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
VENUSTATE CAPSULE ORAL 120 mg
|
ORLISTAT CAPSULE ORAL 120 mg
|
ORLISTAT
|
A08AB01
|
ALIMENTARY TRACT AND METABOLISM
|
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
|
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
|
Peripherally acting antiobesity products
|
orlistat
|
Sepidaj Pharmaceutical Company
|
MINOXIDIL-SEPIDAJ SOLUTION TOPICAL 50 mg/1mL 60 mL
|
MINOXIDIL SOLUTION TOPICAL 50 mg/1mL 60 mL
|
MINOXIDIL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
BISACODYL TABLET, DELAYED RELEASE ORAL 5 mg
|
BISACODYL TABLET, DELAYED RELEASE ORAL 5 mg
|
BISACODYL
|
A06AB02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR CONSTIPATION
|
DRUGS FOR CONSTIPATION
|
Contact laxatives
|
bisacodyl
|
Ronak Pharmaceutical
|
COLISTIMETHATE INJECTION, POWDER, FOR SOLUTION PARENTERAL 4500000 [iU] [iU]
|
COLISTIMETHATE SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 4500000 [iU]
|
COLISTIMETHATE SODIUM
|
J01XB01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
OTHER ANTIBACTERIALS
|
Polymyxins
|
colistin
|
Aburaihan Pharmaceutical Co
|
TESTOSTERONE ENANTHATE INJECTION PARENTERAL 100 mg/1mL mL
|
TESTOSTERONE ENANTHATE INJECTION PARENTERAL 100 mg/1mL
|
TESTOSTERONE ENANTHATE
|
G03BA03
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
|
ANDROGENS
|
3-oxoandrosten (4) derivatives
|
testosterone
|
Amin Pharmaceutical Co.
|
LEVOFECT TABLET ORAL 750 mg
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Tehran Chemie Pharmaceutical Co.
|
DEMITRON TABLET ORAL 4 mg
|
ONDANSETRON TABLET ORAL 4 mg
|
ONDANSETRON
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pfizer
|
DEPO-MEDROL INJECTION, SUSPENSION PARENTERAL 40 mg/1mL mg
|
METHYLPREDNISOLONE ACETATE INJECTION, SUSPENSION PARENTERAL 40 mg/1mL
|
METHYLPREDNISOLONE ACETATE
|
H02AB04
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
CORTICOSTEROIDS FOR SYSTEMIC USE
|
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
|
Glucocorticoids
|
methylprednisolone
|
Raha Pharmaceutical Isfahan Company
|
IBUPROFEN TABLET ORAL 400 mg
|
IBUPROFEN TABLET ORAL 400 mg
|
IBUPROFEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shahre Daru
|
BIQUEL TABLET ORAL 25 mg
|
QUETIAPINE FUMARATE TABLET ORAL 25 mg
|
QUETIAPINE FUMARATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Exir Pharmaceutical Company
|
ZIMEXIR CAPSULE ORAL 500 mg
|
AZITHROMYCIN CAPSULE ORAL 500 mg
|
AZITHROMYCIN
|
J01FA10
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
|
Macrolides
|
azithromycin
|
Toliddaru Pharma. Co.
|
AZITHROMYCIN CAPSULE ORAL 500 mg
|
AZITHROMYCIN CAPSULE ORAL 500 mg
|
AZITHROMYCIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
METHYLPREDNISOLONE ACETATE INJECTION, SUSPENSION PARENTERAL 40 mg/1mL mL
|
METHYLPREDNISOLONE ACETATE INJECTION, SUSPENSION PARENTERAL 40 mg/1mL
|
METHYLPREDNISOLONE ACETATE
|
H02AB04
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
CORTICOSTEROIDS FOR SYSTEMIC USE
|
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
|
Glucocorticoids
|
methylprednisolone
|
Avicenna Laboratories Inc.
|
FLUCONAZOLE TABLET ORAL 150 mg
|
FLUCONAZOLE TABLET ORAL 150 mg
|
FLUCONAZOLE
|
J02AC01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
Triazole derivatives
|
fluconazole
|
Aburaihan Pharmaceutical Co
|
PSORIAMENT OINTMENT TOPICAL 50 ug/1g 30 g
|
CALCIPOTRIOL OINTMENT TOPICAL 50 ug/1g 30 g
|
CALCIPOTRIOL
|
D05AX02
|
DERMATOLOGICALS
|
ANTIPSORIATICS
|
ANTIPSORIATICS FOR TOPICAL USE
|
Other antipsoriatics for topical use
|
calcipotriol
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
SUMATRIPTAN TABLET ORAL 50 mg
|
SUMATRIPTAN (AS SUCCINATE) TABLET ORAL 50 mg
|
SUMATRIPTAN (AS SUCCINATE)
|
N02CC01
|
NERVOUS SYSTEM
|
ANALGESICS
|
ANTIMIGRAINE PREPARATIONS
|
Selective serotonin (5HT1) agonists
|
sumatriptan
|
Raha Pharmaceutical Isfahan Company
|
PSEUPHAN SYRUP ORAL 15 mg/30 mg/5mL mL
|
DEXTROMETHORPHAN / PSEUDOEPHEDRINE SYRUP ORAL 15 mg/30 mg/5mL
|
DEXTROMETHORPHAN / PSEUDOEPHEDRINE
|
R05DA20
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
|
Opium alkaloids and derivatives
|
combinations
|
Soha Pharmaceutical Co.
|
METFORBET TABLET ORAL 1000 mg
|
METFORMIN HYDROCHLORIDE TABLET ORAL 1000 mg
|
METFORMIN HYDROCHLORIDE
|
A10BA02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS USED IN DIABETES
|
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
|
Biguanides
|
metformin
|
Emad Darman Pars
|
ELOCOMAD CREAM TOPICAL 0.1 % 30 g
|
MOMETASONE FUROATE CREAM TOPICAL 0.1 % 30 g
|
MOMETASONE FUROATE
|
D07AC13
|
DERMATOLOGICALS
|
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
|
CORTICOSTEROIDS, PLAIN
|
Corticosteroids, potent (group III)
|
mometasone
|
Toliddaru Pharma. Co.
|
CLINDAMYCIN CAPSULE ORAL 150 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE) CAPSULE ORAL 150 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Daru
|
TETRACYCLINE OINTMENT TOPICAL 3 % 15 g
|
TETRACYCLINE HYDROCHLORIDE OINTMENT TOPICAL 3 % 15 g
|
TETRACYCLINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Daru
|
BIOTIN TABLET ORAL 5 mg
|
BIOTIN TABLET ORAL 5 mg
|
BIOTIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhandarou
|
ABILIZOL TABLET ORAL 15 mg
|
ARIPIPRAZOLE TABLET ORAL 15 mg
|
ARIPIPRAZOLE
|
N05AX12
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Other antipsychotics
|
aripiprazole
|
Shahre Daru
|
THEOMEX CAPSULE, COATED, EXTENDED RELEASE ORAL 200 mg
|
THEOPHYLLINE CAPSULE, COATED, EXTENDED RELEASE ORAL 200 mg
|
THEOPHYLLINE
|
R03DA04
|
RESPIRATORY SYSTEM
|
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
Xanthines
|
theophylline
|
Shahid Ghazi Pharmaceutical Co.
|
DEXTROSE /SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 5 %/0.45 % 500 mL
|
DEXTROSE / SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 5 %/0.45 % 500 mL
|
DEXTROSE / SODIUM CHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pharmachemie
|
PHARMELA-P CREAM TOPICAL 2.5 %/2.5 % 30 g
|
LIDOCAINE / PRILOCAINE CREAM TOPICAL 2.5 %/2.5 % 30 g
|
LIDOCAINE / PRILOCAINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Tehran Darou Pharmaceutical Co.
|
LITMON TABLET ORAL 300 mg
|
LITHIUM CARBONATE TABLET ORAL 300 mg
|
LITHIUM CARBONATE
|
N05AN01
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Lithium
|
lithium
|
Alhavi
|
DEXTROMETHORPHAN-ALHAVI SYRUP ORAL 15 mg/5mL 60 mL
|
DEXTROMETHORPHAN HYDROBROMIDE SYRUP ORAL 15 mg/5mL 60 mL
|
DEXTROMETHORPHAN HYDROBROMIDE
|
R05DA09
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
|
Opium alkaloids and derivatives
|
dextromethorphan
|
Pharmachemie
|
ACETAMINOPHEN SUPPOSITORY RECTAL 325 mg g
|
ACETAMINOPHEN SUPPOSITORY RECTAL 325 mg
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Caspian Tamin Co.
|
OXYTIP INJECTION PARENTERAL 10 U/1mL mL
|
OXYTOCIN INJECTION PARENTERAL 10 U/1mL
|
OXYTOCIN
|
H01BB02
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
|
POSTERIOR PITUITARY LOBE HORMONES
|
Oxytocin and analogues
|
oxytocin
|
Caspian Tamin Co.
|
IPOZINC OINTMENT TOPICAL 25 % 30 g
|
ZINC OXIDE OINTMENT TOPICAL 25 % 30 g
|
ZINC OXIDE
|
D02AB
|
DERMATOLOGICALS
|
EMOLLIENTS AND PROTECTIVES
|
EMOLLIENTS AND PROTECTIVES
|
Zinc products
| null |
Alborzdarou
|
ADIGEL SUSPENSION ORAL 225 mg/200 mg/5 mL 240 mL
|
ALUMINIUM HYDROXIDE / MAGNESIUM HYDROXIDE SUSPENSION ORAL 225 mg/200 mg/5 mL 240 mL
|
ALUMINIUM HYDROXIDE / MAGNESIUM HYDROXIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Raha Pharmaceutical Isfahan Company
|
OXYNOSE SPRAY NASAL 0.05 % 15 mL
|
OXYMETAZOLINE HYDROCHLORIDE SPRAY NASAL 0.05 % 15 mL
|
OXYMETAZOLINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sajad Daru Shargh
|
BISACODYL TABLET, DELAYED RELEASE ORAL 5 mg
|
BISACODYL TABLET, DELAYED RELEASE ORAL 5 mg
|
BISACODYL
|
A06AB02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR CONSTIPATION
|
DRUGS FOR CONSTIPATION
|
Contact laxatives
|
bisacodyl
|
Zahravi Pharmaceutical
|
ACETAPEARL CAPSULE, GELATIN COATED ORAL 500 mg
|
ACETAMINOPHEN CAPSULE, GELATIN COATED ORAL 500 mg
|
ACETAMINOPHEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhandarou
|
HALOPERIDOL SOLUTION ORAL 2 mg/1mL 15 mL
|
HALOPERIDOL (AS LACTATE) SOLUTION ORAL 2 mg/1mL 15 mL
|
HALOPERIDOL (AS LACTATE)
|
N05AD01
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Butyrophenone derivatives
|
haloperidol
|
NEAL PHARMED
|
PANTONILE CAPSULE, DELAYED RELEASE ORAL 40 mg
|
PANTOPRAZOLE CAPSULE, DELAYED RELEASE ORAL 40 mg
|
PANTOPRAZOLE
|
A02BC02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
pantoprazole
|
Pursina Pharmaceutical Co.
|
GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN
|
R05CA03
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
|
Expectorants
|
guaifenesin
|
Sina Darou Laboratories
|
BECLEX INHALANT RESPIRATORY 50 ug/1{dose} 200 {Puff}
|
BECLOMETHASONE DIPROPIONATE INHALANT RESPIRATORY 50 ug/1{dose} 200 {Puff}
|
BECLOMETHASONE DIPROPIONATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
CITALOPRAM-SHAFA TABLET ORAL 20 mg
|
CITALOPRAM TABLET ORAL 20 mg
|
CITALOPRAM
|
N06AB04
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Selective serotonin reuptake inhibitors
|
citalopram
|
Loghman Pharmaceutical & Hygienic (public)
|
ACICLOVIR TABLET ORAL 200 mg
|
ACICLOVIR TABLET ORAL 200 mg
|
ACICLOVIR
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pars Darou
|
CLOTRIMAZOLE CREAM VAGINAL 1 % 50 g
|
CLOTRIMAZOLE CREAM VAGINAL 1 % 50 g
|
CLOTRIMAZOLE
|
G01AF02
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
|
ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
|
Imidazole derivatives
|
clotrimazole
|
Caspian Tamin Co.
|
VIKADIC INJECTION PARENTERAL 10 mg/1mL 1 mL
|
VITAMIN K1 (PHYTOMENADIONE) INJECTION PARENTERAL 10 mg/1mL 1 mL
|
VITAMIN K1 (PHYTOMENADIONE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN
|
R05CA03
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
|
Expectorants
|
guaifenesin
|
Iranian Parenteral And Pharmaceutical Co.
|
SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.45 % 500 mL
|
SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.45 % 500 mL
|
SODIUM CHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Najo
|
POVIDONE IODINE-NAJO SOLUTION TOPICAL 10 % 250 mL
|
POVIDONE IODINE SOLUTION TOPICAL 10 % 250 mL
|
POVIDONE IODINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
RANOLAZE TABLET, EXTENDED RELEASE ORAL 500 mg
|
RANOLAZINE TABLET, EXTENDED RELEASE ORAL 500 mg
|
RANOLAZINE
| null | null | null | null | null | null |
Soha Pharmaceutical Co.
|
PRUVIL SUSPENSION ORAL 100 mg/5mL 120 mL
|
IBUPROFEN SUSPENSION ORAL 100 mg/5mL 120 mL
|
IBUPROFEN
|
M01AE01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Propionic acid derivatives
|
ibuprofen
|
Shahid Ghazi Pharmaceutical Co.
|
HYPERSALINE INJECTION, SOLUTION PARENTERAL 5 % 50 mL
|
SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 5 % 50 mL
|
SODIUM CHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Arimed
|
VENIDIL CAPSULE RESPIRATORY 12 ug
|
FORMOTEROL FUMARATE CAPSULE RESPIRATORY 12 ug
|
FORMOTEROL FUMARATE
|
R03AC13
|
RESPIRATORY SYSTEM
|
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
ADRENERGICS, INHALANTS
|
Selective beta-2-adrenoreceptor agonists
|
formoterol
|
Exir Pharmaceutical Company
|
LOPIROX INJECTION PARENTERAL 20 mg/1mL mg
|
PIROXICAM INJECTION PARENTERAL 20 mg/1mL
|
PIROXICAM
|
M01AC01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Oxicams
|
piroxicam
|
Darou Pakhsh
|
INDOMETHACIN SUPPOSITORY RECTAL 100 mg
|
INDOMETHACIN SUPPOSITORY RECTAL 100 mg
|
INDOMETHACIN
|
M01AB01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
indometacin
|
Razak Labratories
|
MELOXICAM TABLET ORAL 15 mg
|
MELOXICAM TABLET ORAL 15 mg
|
MELOXICAM
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pars Darou
|
ASPIRIN TABLET, DELAYED RELEASE ORAL 81 mg
|
ASA (ACETYLSALICYLIC ACID) TABLET, DELAYED RELEASE ORAL 81 mg
|
ASA (ACETYLSALICYLIC ACID)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pursina Pharmaceutical Co.
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL TABLET ORAL 50 mg
|
ATENOLOL
|
C07AB03
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
atenolol
|
Aburaihan Pharmaceutical Co
|
ESTRADIOL VALERATE TABLET ORAL 2 mg
|
ESTRADIOL VALERATE TABLET ORAL 2 mg
|
ESTRADIOL VALERATE
|
G03CA03
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
|
ESTROGENS
|
Natural and semisynthetic estrogens, plain
|
estradiol
|
Amin Pharmaceutical Co.
|
CLINDAMYCIN CAPSULE ORAL 150 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE) CAPSULE ORAL 150 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE)
|
J01FF01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
|
Lincosamides
|
clindamycin
|
Darou Pakhsh
|
BISOPROLOL TABLET ORAL 5 mg
|
BISOPROLOL FUMARATE TABLET ORAL 5 mg
|
BISOPROLOL FUMARATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pharmachemie
|
IBUPROFEN GEL TOPICAL 5 % 50 g
|
IBUPROFEN GEL TOPICAL 5 % 50 g
|
IBUPROFEN
|
M02AA13
|
MUSCULO-SKELETAL SYSTEM
|
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
|
Antiinflammatory preparations, non-steroids for topical use
|
ibuprofen
|
Jaber Ebne Hayyan
|
PEN INJECTION, POWDER, FOR SOLUTION PARENTERAL 600000 U/300000 U/300000 U [iU]
|
PENICILLIN 6-3-3 INJECTION, POWDER, FOR SOLUTION PARENTERAL 600000 U/300000 U/300000 U
|
PENICILLIN 6-3-3
|
J01RA01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
COMBINATIONS OF ANTIBACTERIALS
|
Combinations of antibacterials
|
penicillins, combinations with other antibacterials
|
Caspian Tamin Co.
|
IPICLOMIN INJECTION PARENTERAL 10 mg/1mL 2 mL
|
DICYCLOMINE HYDROCHLORIDE INJECTION PARENTERAL 10 mg/1mL 2 mL
|
DICYCLOMINE HYDROCHLORIDE
|
A03AA07
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
Synthetic anticholinergics, esters with tertiary amino group
|
dicycloverine
|
G. Pohl-boskamp Gmbh & Co. Kg
|
NITROLINGUAL SPRAY SUBLINGUAL 400 ug/1{dose} 200 mL
|
NITROGLYCERIN SPRAY SUBLINGUAL 400 ug/1{dose} 200 {dose}
|
NITROGLYCERIN
|
C01DA02
|
CARDIOVASCULAR SYSTEM
|
CARDIAC THERAPY
|
VASODILATORS USED IN CARDIAC DISEASES
|
Organic nitrates
|
glyceryl trinitrate
|
Amin Pharmaceutical Co.
|
CIPROFECT TABLET ORAL 500 mg
|
CIPROFLOXACIN TABLET ORAL 500 mg
|
CIPROFLOXACIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Rayhaneh Pharmaceutical Co.
|
PREGABALIN CAPSULE ORAL 150 mg
|
PREGABALIN CAPSULE ORAL 150 mg
|
PREGABALIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
CETRIKIM TABLET ORAL 10 mg
|
CETIRIZINE HYDROCHLORIDE TABLET ORAL 10 mg
|
CETIRIZINE HYDROCHLORIDE
|
R06AE07
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Piperazine derivatives
|
cetirizine
|
Cinnagen Co.
|
CINNAPOIETIN INJECTION PARENTERAL 2000 [iU]/0.3mL [iU]
|
EPOETIN INJECTION PARENTERAL 2000 [iU]/0.3mL
|
EPOETIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Soha Pharmaceutical Co.
|
METFORBET TABLET ORAL 1000 mg
|
METFORMIN HYDROCHLORIDE TABLET ORAL 1000 mg
|
METFORMIN HYDROCHLORIDE
|
A10BA02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS USED IN DIABETES
|
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
|
Biguanides
|
metformin
|
Fresenius Kabi Austria Gmbh
|
PROPOFOL GENTHON INJECTION, EMULSION PARENTERAL 10 mg/1mL 20 mg
|
PROPOFOL INJECTION, EMULSION PARENTERAL 10 mg/1mL 20 mL
|
PROPOFOL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Exir Pharmaceutical Company
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Darou Pakhsh
|
DEXTROSE INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 50 % 500 mL
|
DEXTROSE INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 50 % 500 mL
|
DEXTROSE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Alborzdarou
|
METOCLOPRAMIDE INJECTION PARENTERAL 5 mg/1mL 2 mg
|
METOCLOPRAMIDE INJECTION PARENTERAL 5 mg/1mL 2 mL
|
METOCLOPRAMIDE
|
A03FA01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
PROPULSIVES
|
Propulsives
|
metoclopramide
|
Amin Pharmaceutical Co.
|
LEVOPARKIN TABLET ORAL 100 mg/25 mg
|
LEVODOPA / BENSERAZIDE TABLET ORAL 100 mg/25 mg
|
LEVODOPA / BENSERAZIDE
|
N04BA02
|
NERVOUS SYSTEM
|
ANTI-PARKINSON DRUGS
|
DOPAMINERGIC AGENTS
|
Dopa and dopa derivatives
|
levodopa and decarboxylase inhibitor
|
Cosar Pharmaceutical
|
IRAPRAX POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 100 g
|
CEFIXIME POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 100 mL
|
CEFIXIME
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aryapharmaceutical
|
ACETAMINOPHEN ARYA TABLET ORAL 500 mg
|
ACETAMINOPHEN TABLET ORAL 500 mg
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Shirazserum
|
DEXTROSE INJECTION, SOLUTION INTRAVENOUS 5 % 500 mL
|
DEXTROSE INJECTION, SOLUTION INTRAVENOUS 5 % 500 mL
|
DEXTROSE
|
B05BA03
|
BLOOD AND BLOOD FORMING ORGANS
|
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
|
I.V. SOLUTIONS
|
Solutions for parenteral nutrition
|
carbohydrates
|
Pharmachemie
|
SILDENAFIL TABLET ORAL 100 mg
|
SILDENAFIL (AS CITRATE) TABLET ORAL 100 mg
|
SILDENAFIL (AS CITRATE)
|
G04BE03
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
UROLOGICALS
|
UROLOGICALS
|
Drugs used in erectile dysfunction
|
sildenafil
|
Aburaihan Pharmaceutical Co
|
RHINOFEX TABLET ORAL 180 mg
|
FEXOFENADINE HYDROCHLORIDE TABLET ORAL 180 mg
|
FEXOFENADINE HYDROCHLORIDE
|
R06AX26
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Other antihistamines for systemic use
|
fexofenadine
|
Sobhan Oncology
|
SUNITINIB AQVIDA CAPSULE ORAL 25 mg
|
SUNITINIB CAPSULE ORAL 25 mg
|
SUNITINIB
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Chemidarou
|
ONDANSETRON INJECTION PARENTERAL 2 mg/1 mL 2 mL
|
ONDANSETRON INJECTION PARENTERAL 2 mg/1 mL 2 mL
|
ONDANSETRON
|
A04AA01
|
ALIMENTARY TRACT AND METABOLISM
|
ANTIEMETICS AND ANTINAUSEANTS
|
ANTIEMETICS AND ANTINAUSEANTS
|
Serotonin (5HT3) antagonists
|
ondansetron
|
Loghman Pharmaceutical & Hygienic (public)
|
CEFALEXIN POWDER, FOR SUSPENSION ORAL 250 mg/5 mL 100 mL
|
CEFALEXIN POWDER, FOR SUSPENSION ORAL 250 mg/5 mL 100 mL
|
CEFALEXIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
PRAZOSIN TABLET ORAL 1 mg
|
PRAZOSIN TABLET ORAL 1 mg
|
PRAZOSIN
|
C02CA01
|
CARDIOVASCULAR SYSTEM
|
ANTIHYPERTENSIVES
|
ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
|
Alpha-adrenoreceptor antagonists
|
prazosin
|
Alborzdarou
|
ALFEN-XL TABLET, EXTENDED RELEASE ORAL 100 mg
|
DICLOFENAC SODIUM TABLET, EXTENDED RELEASE ORAL 100 mg
|
DICLOFENAC SODIUM
|
M01AB05
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
diclofenac
|
Raha Pharmaceutical Isfahan Company
|
THEOPHYLLINE-G SOLUTION ORAL 50 mg/30 mg/5mL 120 mL
|
THEOPHYLLINE / GUAIFENESIN SOLUTION ORAL 50 mg/30 mg/5mL 120 mL
|
THEOPHYLLINE / GUAIFENESIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Behvazan Pharmaceutical
|
INDOMETHACIN-BEHVAZAN SUPPOSITORY RECTAL 100 mg
|
INDOMETHACIN SUPPOSITORY RECTAL 100 mg
|
INDOMETHACIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pursina Pharmaceutical Co.
|
DIPHENHYDRAMINE SOLUTION ORAL 12.5 mg/5mL 60 mL
|
DIPHENHYDRAMINE HYDROCHLORIDE SOLUTION ORAL 12.5 mg/5mL 60 mL
|
DIPHENHYDRAMINE HYDROCHLORIDE
|
R06AA02
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Aminoalkyl ethers
|
diphenhydramine
|
Caspian Tamin Co.
|
IPACIN INJECTION PARENTERAL 250 mg/1mL 2 mL
|
AMIKACIN (AS SULFATE) INJECTION PARENTERAL 250 mg/1mL 2 mL
|
AMIKACIN (AS SULFATE)
|
J01GB06
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
AMINOGLYCOSIDE ANTIBACTERIALS
|
Other aminoglycosides
|
amikacin
|
Alhavi
|
DICYCLOMINE-ALHAVI ELIXIR ORAL 10 mg/5mL 60 mL
|
DICYCLOMINE HYDROCHLORIDE ELIXIR ORAL 10 mg/5mL 60 mL
|
DICYCLOMINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
SEVABONAT TABLET ORAL 800 mg
|
SEVELAMER CARBONATE TABLET ORAL 800 mg
|
SEVELAMER CARBONATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
OMEPRAKIM CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Caspian Tamin Co.
|
DALADIC INJECTION PARENTERAL 150 mg/1mL 2 mL
|
CLINDAMYCIN (AS PHOSPHATE) INJECTION PARENTERAL 150 mg/1mL 2 mL
|
CLINDAMYCIN (AS PHOSPHATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.